×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
PATIENTS AS EXPERTS IN DRUG REGULATION
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
PATIENTS AS EXPERTS IN DRUG REGULATION
Speaker(s)
Regulatory View
Ian Hudson
Bill and Melinda Gates Foundation, United States
Senior Advisor, Integrated Development
Patient View
Jayne Spink
MS Society, United Kingdom
Director of Policy & Research
Industry and Patient Associations
Keith Allan
Novartis Pharma AG, Switzerland
Director of Global Advocacy
Have an account?